Campaign for Health Care Reform

DEFENDING REFORMS FROM BIG PHARMA—MASSPIRG Legislative Director Deirdre Cummings, alongside State Sen. Mark Montigny (New Bedford), urges lawmakers to keep the Rx Gift Ban in place. MASSPIRG is committed to helping keep health costs down for consumers.

BEING A WATCHDOG ON HEALTH CARE REFORM

America’s health care system is structured to profit the drug industry, insurance companies, and medical specialists, not better health outcomes for you.

The Affordable Care Act was an historic step toward getting health care costs under control, but more needs to be done to protect its solvency as demographics change and costs continue to rise. We can do this without undermining the fundamental goal of ensuring all Americans have access to quality, affordable health care.

In Massachusetts, which paved the path for the federal law with our 2006 reforms, our priority now is to make sure state leaders focus on how on to deliver lower costs and better quality for consumers.

The cost of inaction to Massachusetts’ families would be overwhelming:

• If we don’t get our leaders to squeeze out the health care system's costly inefficiencies, the full cost of premiums will climb to $26,069 for families and $8,845 for individual employer-sponsored insurance by 2016.

• With these projected increases, the cost of a family health insurance policy will be equal to 41.2% of median household income.

To ensure Massachusetts continues to develop leading models of reform, MASSPIRG joined Campaign for Better Care, a broad coalition of organizations to tackle some of the biggest challenges left in health reform — lowering the cost while promoting more coordinated, efficient and better care.

Issue updates

News Release | U.S. PIRG | Public Health, Consumer Protection, Health Care

Second recall of King Bio’s homeopathic drugs in the past month

King Bio Inc. issued the second significant voluntary recall since late July of their homeopathic drugs on Wednesday. Safety concerns over homeopathic drugs extend beyond King Bio as over the past several years, the FDA has issued recalls to several companies for a variety of health products from zinc-containing intranasal medicine to asthma drugs with toxic ingredients. 

> Keep Reading
News Release | MASSPIRG | Public Health, Consumer Protection, Health Care

Some Good, Some Bad in Obama Executive Order on Protecting Antibiotics

New executive order on antibiotics takes several important steps necessary to control the spread of antibiotic-resistant bacteria, it misses the opportunity to call for critical reforms in the agricultural sector that are essential to protect public health. 

> Keep Reading
News Release | MASSPIRG Education Fund | Health Care

Group Calls on FDA to Protect Public Health by Regulating Antibiotic Use at Factory Farms

As outlined in our new report entitled Weak Medicine:  Why the FDA's New Guidelines Are Inadequate To Curb Antibiotic Resistance and Protect Public Health.  Guidelines issued by FDA last year lack the restrictions necessary to fully combat the increase in antibiotic-resistant bacteria documented by world health experts.

> Keep Reading
Report | MASSPIRG Education Fund | Health Care

Weak Medicine

 As outlined in our new report, Weak Medicine:  Why the FDA's New Guidelines Are Inadequate To Curb Antibiotic Resistance and Protect Public Health. Guidelines issued by the FDA last year lack the restrictions necessary to fully combat the increase in antibiotic-resistant bacteria documents by world health experts.

> Keep Reading
Report | U.S. PIRG Education Fund | Health Care

Making the Grade

When it comes to health care, there are few magic-bullet solutions for the many problems consumers face in the marketplace: insurers don’t compete for their business, leading to higher prices and lower quality. Important information about coverage is buried in the fine print, making it hard to know what’s really covered or which plan is right. And costs are continuing their unsustainable rise.

> Keep Reading

Pages

News Release | U.S. PIRG | Public Health, Consumer Protection, Health Care

Second recall of King Bio’s homeopathic drugs in the past month

King Bio Inc. issued the second significant voluntary recall since late July of their homeopathic drugs on Wednesday. Safety concerns over homeopathic drugs extend beyond King Bio as over the past several years, the FDA has issued recalls to several companies for a variety of health products from zinc-containing intranasal medicine to asthma drugs with toxic ingredients. 

> Keep Reading
News Release | MASSPIRG | Public Health, Consumer Protection, Health Care

Some Good, Some Bad in Obama Executive Order on Protecting Antibiotics

New executive order on antibiotics takes several important steps necessary to control the spread of antibiotic-resistant bacteria, it misses the opportunity to call for critical reforms in the agricultural sector that are essential to protect public health. 

> Keep Reading
News Release | MASSPIRG Education Fund | Health Care

Group Calls on FDA to Protect Public Health by Regulating Antibiotic Use at Factory Farms

As outlined in our new report entitled Weak Medicine:  Why the FDA's New Guidelines Are Inadequate To Curb Antibiotic Resistance and Protect Public Health.  Guidelines issued by FDA last year lack the restrictions necessary to fully combat the increase in antibiotic-resistant bacteria documented by world health experts.

> Keep Reading
Report | MASSPIRG Education Fund | Health Care

Weak Medicine

 As outlined in our new report, Weak Medicine:  Why the FDA's New Guidelines Are Inadequate To Curb Antibiotic Resistance and Protect Public Health. Guidelines issued by the FDA last year lack the restrictions necessary to fully combat the increase in antibiotic-resistant bacteria documents by world health experts.

> Keep Reading
Report | U.S. PIRG Education Fund | Health Care

Making the Grade

When it comes to health care, there are few magic-bullet solutions for the many problems consumers face in the marketplace: insurers don’t compete for their business, leading to higher prices and lower quality. Important information about coverage is buried in the fine print, making it hard to know what’s really covered or which plan is right. And costs are continuing their unsustainable rise.

> Keep Reading
Report | Division of Health Care Finance and Policy (DHCFP) | Budget, Health Care, Higher Ed

Student Health Program Baseline Report

The Student Health Program Baseline Report is the first comprehensive report on the Student Health Program (SHP). The report  aims to provide an overview of the Program's enrollment and financial performance at Massachusetts colleges and universities, as well as serve as a baseline for SHP comparisons in the future improving transparency within the SHP marketplace.

> Keep Reading
Report | Health Care

Health Care in Crisis

Our health care system is in crisis. Without swift action, that crisis could threaten every Massachusetts family’s health and finances.

> Keep Reading

Pages

News Release | U.S. PIRG

King Bio Inc. issued the second significant voluntary recall since late July of their homeopathic drugs on Wednesday. Safety concerns over homeopathic drugs extend beyond King Bio as over the past several years, the FDA has issued recalls to several companies for a variety of health products from zinc-containing intranasal medicine to asthma drugs with toxic ingredients. 

News Release | MASSPIRG

New executive order on antibiotics takes several important steps necessary to control the spread of antibiotic-resistant bacteria, it misses the opportunity to call for critical reforms in the agricultural sector that are essential to protect public health. 

News Release | MASSPIRG Education Fund

As outlined in our new report entitled Weak Medicine:  Why the FDA's New Guidelines Are Inadequate To Curb Antibiotic Resistance and Protect Public Health.  Guidelines issued by FDA last year lack the restrictions necessary to fully combat the increase in antibiotic-resistant bacteria documented by world health experts.

Report | MASSPIRG Education Fund

 As outlined in our new report, Weak Medicine:  Why the FDA's New Guidelines Are Inadequate To Curb Antibiotic Resistance and Protect Public Health. Guidelines issued by the FDA last year lack the restrictions necessary to fully combat the increase in antibiotic-resistant bacteria documents by world health experts.

Report | U.S. PIRG Education Fund

When it comes to health care, there are few magic-bullet solutions for the many problems consumers face in the marketplace: insurers don’t compete for their business, leading to higher prices and lower quality. Important information about coverage is buried in the fine print, making it hard to know what’s really covered or which plan is right. And costs are continuing their unsustainable rise.

View AllRSS Feed

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.
Optional Member Code

Support Us

Your donation supports MASSPIRG's work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.




MASSPIRG Education Fund is part of The Public Interest Network, which operates and supports organizations committed to a shared vision of a better world and a strategic approach to getting things done.